Vitamin D nutritional status and bone turnover markers in childhood acute lymphoblastic leukemia survivors: A PETALE study. Issue 2 (April 2019)
- Record Type:
- Journal Article
- Title:
- Vitamin D nutritional status and bone turnover markers in childhood acute lymphoblastic leukemia survivors: A PETALE study. Issue 2 (April 2019)
- Main Title:
- Vitamin D nutritional status and bone turnover markers in childhood acute lymphoblastic leukemia survivors: A PETALE study
- Authors:
- Delvin, E.
Alos, N.
Rauch, F.
Marcil, V.
Morel, S.
Boisvert, M.
Lecours, M.-A.
Laverdière, C.
Sinnett, D.
Krajinovic, M.
Dubois, J.
Drouin, S.
Lefebvre, G.
Samoilenko, M.
Nyalendo, C.
Cavalier, E.
Levy, E. - Abstract:
- Summary: Background: The remarkable progress in the treatment of childhood acute lymphoblastic leukemia (cALL) has led to a survival rate reaching 90%. This success story is unfortunately linked to increased risk of impaired skeletal mass accumulation during childhood and adolescence, predisposing the patients to osteoporosis and pathological fractures at adulthood. Objective: This study aims at characterizing the vitamin D status and bone health biomarkers in a well-characterized cohort of cALL survivors. Results: Food frequency questionnaires reveal that (i) the total vitamin D intake varies greatly (44–2132 IU/d), (ii) only 16.8% of the participants consume vitamin D supplements, and (iii) 74% of survivors' intakes are below the Recommended Daily Intakes (400 IU/d). For the 42 participants taking vitamin D supplements, the median (2.5–97.5 %iles ) intake is 600 IU/d (21.2–1972 IU/d). Sixteen participants are vitamin D deficient (<30 nM) and 66 insufficient (≥30 – <50 nM). Serum 24, 25(OH)2 D3 concentrations are directly related to those of 25OHD3, and those of 3-epi-25OHD3 below the Lower Limit of Quantification in most samples. The participants' serum concentrations of cross-linked C-telopeptide of type-I collagen and intact amino-terminal pro-peptide of type-I collagen decrease steadily with age, leveling at adulthood, and are at all times higher in males. Conclusion: The present study shows that the prevalence of vitamin D insufficiency or deficiency is not greater inSummary: Background: The remarkable progress in the treatment of childhood acute lymphoblastic leukemia (cALL) has led to a survival rate reaching 90%. This success story is unfortunately linked to increased risk of impaired skeletal mass accumulation during childhood and adolescence, predisposing the patients to osteoporosis and pathological fractures at adulthood. Objective: This study aims at characterizing the vitamin D status and bone health biomarkers in a well-characterized cohort of cALL survivors. Results: Food frequency questionnaires reveal that (i) the total vitamin D intake varies greatly (44–2132 IU/d), (ii) only 16.8% of the participants consume vitamin D supplements, and (iii) 74% of survivors' intakes are below the Recommended Daily Intakes (400 IU/d). For the 42 participants taking vitamin D supplements, the median (2.5–97.5 %iles ) intake is 600 IU/d (21.2–1972 IU/d). Sixteen participants are vitamin D deficient (<30 nM) and 66 insufficient (≥30 – <50 nM). Serum 24, 25(OH)2 D3 concentrations are directly related to those of 25OHD3, and those of 3-epi-25OHD3 below the Lower Limit of Quantification in most samples. The participants' serum concentrations of cross-linked C-telopeptide of type-I collagen and intact amino-terminal pro-peptide of type-I collagen decrease steadily with age, leveling at adulthood, and are at all times higher in males. Conclusion: The present study shows that the prevalence of vitamin D insufficiency or deficiency is not greater in cALL survivors compared to the general Canadian population despite low vitamin D food and supplement intakes. Furthermore, there seem to be no overt imbalance in the gender- and age-adjusted serum bone turnover marker concentrations. Highlights: Majority of cALL survivors have low vitamin D food and supplement intakes. The serum 25OHD3 status of cALL survivors is comparable to the Canadian population. cAll survivors show no overt imbalance in serum bone turnover marker concentrations. … (more)
- Is Part Of:
- Clinical nutrition. Volume 38:Issue 2(2019)
- Journal:
- Clinical nutrition
- Issue:
- Volume 38:Issue 2(2019)
- Issue Display:
- Volume 38, Issue 2 (2019)
- Year:
- 2019
- Volume:
- 38
- Issue:
- 2
- Issue Sort Value:
- 2019-0038-0002-0000
- Page Start:
- 912
- Page End:
- 919
- Publication Date:
- 2019-04
- Subjects:
- Acute lymphoblastic leukemia -- 25-Hydroxyvitamin D3 -- Bone resorption -- Bone formation -- CTX -- P1NP
Critically ill -- Nutrition -- Periodicals
Diet therapy -- Periodicals
Parenteral feeding -- Periodicals
Enteral feeding -- Periodicals
Enteral Nutrition -- Periodicals
Parenteral Nutrition -- Periodicals
Metabolism -- Periodicals
Diétothérapie -- Périodiques
Alimentation parentérale -- Périodiques
Alimentation entérale -- Périodiques
Nutrition -- Périodiques
Diet therapy
Enteral feeding
Nutrition
Parenteral feeding
Electronic journals
Periodicals
Electronic journals
615.854 - Journal URLs:
- http://www.sciencedirect.com/science/journal/02615614 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.clnu.2018.02.006 ↗
- Languages:
- English
- ISSNs:
- 0261-5614
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.314500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 9668.xml